|
|
|
|
||
Re: Cascade explanation and Ziopharms techDoes this not tie into the comments that controlling IL-12 is the Celgene's co-founder "holy grail" statement ... because this cytokine has properties that go after multi-clonal antigens in brain cancers (Dr. Chioccia's statement)? Thanks. Nice gift -- your cancer overview. |
return to message board, top of board |